Continue your education throughout the year with AHA. From specialty conferences to Scientific Sessions 2017, AHA offers excellent education throughout the year.

Five conferences will be held in 2017, each focusing on a unique specialty.

Whether you missed a session or seek to review one you attended, you can gain access to every presentation delivered at Scientific Sessions 2016 with Sessions OnDemand™ Premium. This valuable video library gives you unlimited online and mobile access to Sessions presentations.

New technology to improve professional approaches and patient outcomes was on display in sessions, demonstrations, competitions and even a lounge at Scientific Sessions 2016. Two different types of technology advances were highlighted in the HealthTech Competition and the Early Career Lounge.

Formal education presentations were a highlight of Scientific Sessions 2016, but interacting with researchers and other attendees in a variety of formats helped push learning opportunities to another level. Those opportunities ranged from meeting with renowned researchers to talking to poster presenters to networking with peers.

Scientific Sessions 2016 was a big event for the medical community, and it attracted a variety of renowned speakers. Two of those big speakers — Robert Califf, MD, Food and Drug Administration commissioner, and Victor Dzau, MD, president of the Institute of Medicine — looked at the role of cardiovascular medicine in the near future.

Scientific Sessions 2016 featured programs that explored specialized information for increased learning for specific groups. These programs aimed at aiding cardiovascular nurses, exploring advances in resuscitation science and expanding general knowledge of genomics.

The Simulation Zone proved popular in its second-year appearance at Scientific Sessions 2016. It featured four regularly scheduled demonstrations that drew large crowds of participants. The simulations gave attendees an opportunity to test their knowledge, skills and critical thinking.

Full-day Frontiers in Science Summits were a great success during Scientific Sessions 2016 based on feedback from those attending the sessions. The summits focused on Arrhythmia Research, Stem Cells, Thrombosis and Vascular Disease. Additionally, the Precision Medicine Summit was held during Scientific Sessions.

Results from the Trial of Ularitide’s Efficacy and Safety in Patients with Acute Heart Failure suggest that the standard model of AHF is incomplete. The trial found that vasodilation and the subsequent reduction of myocardial congestion improves heart failure outcomes during treatment but has no effect on long-term cardiovascular outcomes.

Patients who have peripheral artery disease will likely respond equally well whether treated with ticagrelor or clopidogrel as monotherapy, according to results from the Examining Use of Ticagrelor in PAD trial.